GlassScriptPhysician profile
Joseph John Lynott
NPI 1780249359
$29,157.43
in general payments reported to CMS, 2019-2025
23 companies · $2,614 in 2025
The $2,614 reported for 2025 was more than what 88% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,539 · 2020: $813 · 2021: $5,157 · 2022: $9,828 · 2023: $3,340 · 2024: $5,866 · 2025: $2,614.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,252 · Travel and Lodging: $5,569.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,251.97 |
| Travel and Lodging | $5,568.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $13,734.18 | 2019-2025 | Infinity, Inbone, Hoffmann |
| Orthofix Medical, INC. | $5,912.60 | 2021-2025 | Truelok, Trinity Elite, Physio-Stim |
| Legacy Ortho LLC | $3,600.00 | 2021-2022 | |
| Paragon 28, INC. | $1,237.19 | 2019-2025 | Additive Orthopedics, Portfolio, Jaws |
| Smith+Nephew, INC. | $911.78 | 2020-2025 | Stravix, Bioinductive Implant With Arthroscopic Delivery System - Medium, Bone Anchors With Arthroscopic Delivery System |
| Medical Device Business Services, INC. | $622.62 | 2023 | |
| International Life Sciences | $605.44 | 2023-2024 | Flexband |
| Bioventus LLC | $477.90 | 2019-2022 | |
| Depuy Synthes Sales INC. | $290.74 | 2021-2025 | Motoband, Hammerlock |
| Fusion Orthopedics USA, LLC | $262.20 | 2025 | |
| Wright Medical Technology, INC. | $256.64 | 2019-2020 | |
| Horizon Therapeutics Plc | $247.24 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $233.29 | 2019-2020 | |
| Musculoskeletal Transplant Foundation INC. | $195.12 | 2025 | |
| Heron Therapeutics, INC. | $127.86 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $125.41 | 2023 | Allograft Tissue |
| Organogenesis INC. | $117.60 | 2023 | Puraply |
| Pfizer INC. | $47.19 | 2019-2021 | |
| Integra Lifesciences Corporation | $43.07 | 2022 | |
| In2bones USA, LLC | $42.93 | 2022 | |
| Paratek Pharmaceuticals, INC. | $24.68 | 2024 | Nuzyra |
| Baxter Healthcare | $23.25 | 2019 | |
| Abbvie INC. | $18.50 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Lynott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.